Repare Therapeutics Inc. Annual Nonoperating Income (Expense) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Repare Therapeutics Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2019 to 2023.
  • Repare Therapeutics Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $2.45M, a 24.4% decline year-over-year.
  • Repare Therapeutics Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $11.3M, a 13% decline year-over-year.
  • Repare Therapeutics Inc. annual Nonoperating Income (Expense) for 2023 was $13M, a 121% increase from 2022.
  • Repare Therapeutics Inc. annual Nonoperating Income (Expense) for 2022 was $5.9M, a 7868% increase from 2021.
  • Repare Therapeutics Inc. annual Nonoperating Income (Expense) for 2021 was $74K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $13M +$7.15M +121% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $5.9M +$5.82M +7868% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $74K +$514K Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
2020 -$440K +$204K +31.7% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
2019 -$644K Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.